[Other] Efficacy and safety of pembrolizumab plus albumin-bound paclitaxel and nedaplatin as a first-line therapy for advanced esophageal squamous cell carcinoma.

 Close Closed
OmarElkoumi Post time 2024-4-25 11:50:57 | Show all posts |Read mode
Reward10points

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Intermediate member
  • post

  • reply

  • points

    385

Latest Reply



Return to the list